
Clover Health announced that its Interim CFO, Clay Thornton, will present at the UBS Global Healthcare Conference on November 9, 2026. The presentation will include a live webcast and Q&A session accessible via Clover Health's investor relations website. This event highlights Clover Health's ongoing efforts to showcase its technology-driven approach to improving healthcare for Medicare beneficiaries. Investors can expect insights into the company's strategy and performance during the session.
Clover Health's market cap stands at $2.44 billion as of October 27, 2026, 03:23 WIB, with a daily trading volume of 3,318,884 shares on Pluang. The stock price is currently $4.54, down 1.41% for the day. This trading activity provides context for the upcoming UBS Global Healthcare Conference presentation by Clover Health's Interim CFO, highlighting investor interest in the company's healthcare technology strategy.